These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 23833124)
1. Frequent antibiotic use and second breast cancer events. Wirtz HS; Buist DS; Gralow JR; Barlow WE; Gray S; Chubak J; Yu O; Bowles EJ; Fujii M; Boudreau DM Cancer Epidemiol Biomarkers Prev; 2013 Sep; 22(9):1588-99. PubMed ID: 23833124 [TBL] [Abstract][Full Text] [Related]
2. Associations between diabetes medication use and risk of second breast cancer events and mortality. Calip GS; Yu O; Hoskins KF; Boudreau DM Cancer Causes Control; 2015 Aug; 26(8):1065-77. PubMed ID: 25956271 [TBL] [Abstract][Full Text] [Related]
3. Comparative safety of cardiovascular medication use and breast cancer outcomes among women with early stage breast cancer. Boudreau DM; Yu O; Chubak J; Wirtz HS; Bowles EJ; Fujii M; Buist DS Breast Cancer Res Treat; 2014 Apr; 144(2):405-16. PubMed ID: 24557337 [TBL] [Abstract][Full Text] [Related]
4. Risk of second breast cancer events with chronic opioid use in breast cancer survivors. Boudreau DM; Chen L; Yu O; Bowles EJA; Chubak J Pharmacoepidemiol Drug Saf; 2019 May; 28(5):740-753. PubMed ID: 30945381 [TBL] [Abstract][Full Text] [Related]
5. Metabolic syndrome and outcomes following early-stage breast cancer. Calip GS; Malone KE; Gralow JR; Stergachis A; Hubbard RA; Boudreau DM Breast Cancer Res Treat; 2014 Nov; 148(2):363-77. PubMed ID: 25301086 [TBL] [Abstract][Full Text] [Related]
6. Use of Antihypertensive Medications and Risk of Adverse Breast Cancer Outcomes in a SEER-Medicare Population. Chen L; Chubak J; Boudreau DM; Barlow WE; Weiss NS; Li CI Cancer Epidemiol Biomarkers Prev; 2017 Nov; 26(11):1603-1610. PubMed ID: 28807926 [No Abstract] [Full Text] [Related]
7. Diabetes Treatments and Risks of Adverse Breast Cancer Outcomes among Early-Stage Breast Cancer Patients: A SEER-Medicare Analysis. Chen L; Chubak J; Boudreau DM; Barlow WE; Weiss NS; Li CI Cancer Res; 2017 Nov; 77(21):6033-6041. PubMed ID: 28935814 [TBL] [Abstract][Full Text] [Related]
8. Evidence for Detection Bias by Medication Use in a Cohort Study of Breast Cancer Survivors. Wirtz HS; Calip GS; Buist DSM; Gralow JR; Barlow WE; Gray S; Boudreau DM Am J Epidemiol; 2017 Apr; 185(8):661-672. PubMed ID: 28338879 [TBL] [Abstract][Full Text] [Related]
9. Enhancing Breast Cancer Recurrence Algorithms Through Selective Use of Medical Record Data. Kroenke CH; Chubak J; Johnson L; Castillo A; Weltzien E; Caan BJ J Natl Cancer Inst; 2016 Mar; 108(3):. PubMed ID: 26582243 [TBL] [Abstract][Full Text] [Related]
10. Postdiagnosis alcohol consumption and breast cancer prognosis in the after breast cancer pooling project. Kwan ML; Chen WY; Flatt SW; Weltzien EK; Nechuta SJ; Poole EM; Holmes MD; Patterson RE; Shu XO; Pierce JP; Caan BJ Cancer Epidemiol Biomarkers Prev; 2013 Jan; 22(1):32-41. PubMed ID: 23150063 [TBL] [Abstract][Full Text] [Related]
11. Statin use and breast cancer risk in a large population-based setting. Boudreau DM; Yu O; Miglioretti DL; Buist DS; Heckbert SR; Daling JR Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):416-21. PubMed ID: 17372235 [TBL] [Abstract][Full Text] [Related]
12. Breast cancer recurrence in relation to antidepressant use. Chubak J; Bowles EJ; Yu O; Buist DS; Fujii M; Boudreau DM Cancer Causes Control; 2016 Jan; 27(1):125-36. PubMed ID: 26518198 [TBL] [Abstract][Full Text] [Related]
13. Multivitamin use and breast cancer outcomes in women with early-stage breast cancer: the Life After Cancer Epidemiology study. Kwan ML; Greenlee H; Lee VS; Castillo A; Gunderson EP; Habel LA; Kushi LH; Sweeney C; Tam EK; Caan BJ Breast Cancer Res Treat; 2011 Nov; 130(1):195-205. PubMed ID: 21559824 [TBL] [Abstract][Full Text] [Related]
14. An Electronic Health Record-based Algorithm to Ascertain the Date of Second Breast Cancer Events. Chubak J; Onega T; Zhu W; Buist DSM; Hubbard RA Med Care; 2017 Dec; 55(12):e81-e87. PubMed ID: 29135770 [TBL] [Abstract][Full Text] [Related]
15. Tamoxifen and Antidepressant Drug Interaction in a Cohort of 16,887 Breast Cancer Survivors. Haque R; Shi J; Schottinger JE; Ahmed SA; Cheetham TC; Chung J; Avila C; Kleinman K; Habel LA; Fletcher SW; Kwan ML J Natl Cancer Inst; 2016 Mar; 108(3):. PubMed ID: 26631176 [TBL] [Abstract][Full Text] [Related]
16. Antibiotic use in relation to the risk of breast cancer. Velicer CM; Heckbert SR; Lampe JW; Potter JD; Robertson CA; Taplin SH JAMA; 2004 Feb; 291(7):827-35. PubMed ID: 14970061 [TBL] [Abstract][Full Text] [Related]
17. Mammography use, breast cancer stage at diagnosis, and survival among older women. McCarthy EP; Burns RB; Freund KM; Ash AS; Shwartz M; Marwill SL; Moskowitz MA J Am Geriatr Soc; 2000 Oct; 48(10):1226-33. PubMed ID: 11037009 [TBL] [Abstract][Full Text] [Related]
18. No association between low-dose aspirin use and breast cancer outcomes overall: a Swedish population-based study. Frisk G; Ekberg S; Lidbrink E; Eloranta S; Sund M; Fredriksson I; Lambe M; Smedby KE Breast Cancer Res; 2018 Nov; 20(1):142. PubMed ID: 30458873 [TBL] [Abstract][Full Text] [Related]
19. Increased Mortality with Repeat Lumpectomy Alone After Ipsilateral Breast Tumor Recurrence. Su Y; Guo R; Xue J; Chi Y; Chi W; Wang J; Yang B; Wu J Oncologist; 2019 Sep; 24(9):e818-e827. PubMed ID: 30842240 [TBL] [Abstract][Full Text] [Related]
20. Hazard of recurrence among women after primary breast cancer treatment--a 10-year follow-up using data from SEER-Medicare. Cheng L; Swartz MD; Zhao H; Kapadia AS; Lai D; Rowan PJ; Buchholz TA; Giordano SH Cancer Epidemiol Biomarkers Prev; 2012 May; 21(5):800-9. PubMed ID: 22426147 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]